FDA OKs Maintenance Option for High-Risk Neuroblastoma
(MedPage Today) -- The FDA approved oral eflornithine (Iwilfin) for children and adults with high-risk neuroblastoma, the agency announced on Wednesday.
Specifically, the ornithine decarboxylase inhibitor is indicated as a maintenance therapy...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news